RxDoctor Payments Data

Joseph Holley, MD

General Practice · Knoxville, TNNPI 1952342586

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. ZOLL Medical Corporation accounts for 93.0% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $15,749 and has fallen 90.2% since, to $1,541 in 2025. Among general practice clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,642in general payments, 2019–2025

Across 47 payments — averaging $588.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ZOLL Medical Corporation$26K
  • Stryker$2K
  • Emergent Biosolutions Inc.$110
  • Mercury Enterprises, Inc.$12
  • Merck$12
$298,195in research payments, 2019–2025

Across 5 payments — averaging $59,639 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$298K

What the payments were for

  • Consulting fees$11,32541%
  • Speaking & faculty fees$3,20012%
  • Travel & lodging$10,51438%
  • Food & beverage$2,6039%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
ZOLL Medical Corporation26$25,707
Stryker18$1,801
Emergent Biosolutions Inc.1$110
Mercury Enterprises, Inc.1$12
Merck1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,642 in reported general payments places this provider in the 95th percentile of 1,632 general practice providers in Tennessee.

See all general practice providers in Tennessee

Medicare billing

Part B allowed, 2024
$53,809
Medicare patients
288
Services billed
2,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf435$133,457
ShingrixVaricella-Zoster Ge/As01b/Pf571$126,907
AbrysvoRsv Vacc, Pref A And Pref B/Pf282$90,301
Boostrix TdapDiphth,pertuss(Acell),tet Vac245$17,086
Typhim ViTyphoid Vi Polysacch Vaccine92$14,151
TwinrixHepatitis A And B Vaccine/Pf85$12,617
Yf-VaxYellow Fever Vaccine Live/Pf47$10,711
Atovaquone-Proguanil HclAtovaquone/Proguanil Hcl45$4,306
MenquadfiMening Vac A,c,y,w135,c-Tet/Pf19$3,609
M-M-R Ii VaccineMeasles,mumps,rubella Vacc/Pf24$2,776
VaqtaHepatitis A Virus Vaccine/Pf27$2,744
IpolPoliomyelitis Vaccine, Killed28$1,857
TdvaxTetanus, Diphtheria Tox,adult29$1,476

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckVaqta$12$2,74427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,632 general practice providers in Tennessee.

Other general practice in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →